IMO this is very good news for NVTR.
"Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $8.00 per share. The offering is expected to close on or about February 5, 2018, subject to customary closing conditions. In addition, Nuvectra has granted the underwriters a 30-day option to purchase up to 423,750 additional shares of common stock on the same terms and conditions."
Growth capital and a solid floor for share price. Win, win IMO.
